alexa Anticancer Compounds from Chaetomium globosum | Open Access Journals
ISSN: 2161-1009
Biochemistry & Analytical Biochemistry
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Anticancer Compounds from Chaetomium globosum

Moubasher Hani* and Hamed Eman

Department of Botany and Microbiology, Faculty of Science, Cairo University, Giza, Egypt

*Corresponding Author:
Moubasher Hani
Department of Botany and Microbiology Department
Faculty of Science, Cairo University, Giza, Egypt
E-mail: [email protected]

Received Date: February 28, 2015; Accepted Date: April 21, 2015; Published Date: April 23, 2015

Citation: Hani M, Eman H (2015) Anticancer Compounds from Chaetomium globosum. Biochem Anal Biochem 4:174. doi:10.4172/2161-1009.1000174

Copyright: © 2015 Hani M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Biochemistry & Analytical Biochemistry


The present work resulted in isolation and purification of two potential anticancer compounds from Chaetomium globosum isolated from Egyptian soil. The two compounds were tested against Michigan Cancer Foundation-7(MCF-7) breast cancer cell line and Hepatocellular carcinoma, Human (HEPG-2) a human liver carcinoma cell line and showed inhibition effect on the proliferation of two cell lines. The structures of the two pure compounds were elucidated by HNMR and Mass spectroscopy as methyl 9-dihydro-8-trihydroxy-9-oxo-Hxanthene- 1-carboxylate as a member of xanthones and (E)-methyl 2-hydroxy-6, 6-dimethyl hept-3-enoate.


Chaetomium globosum; MCF-7 cell line; HEPG-2 cell line; Anticancer compounds; Cytotoxicity; Xanthones


Chaetomium Kunze is a large genus of the Chaetomiaceae Winter Sordariales Chad. Ex D. Hawksw. and O. E. Erikss., Ascomycota which comprises more than one hundred species. Chaetomium has been reported to play a major role in the decomposition of cellulose-made materials. As well as being a contaminant, Chaetomium spp. are also encountered as causative agents of infections in humans. A few cases of fatal deep infections due to Chaetomium atrobrunneum have been reported in the immune compromised host. Other clinical syndromes include brain abscess, peritonitis, and onychomycosis [1,2]. Secondary metabolites are organic compounds that are not directly involved in the normal growth, development, or reproduction of an organism. Unlike primary metabolites, absence of secondary metabolites does not result in immediate death [3]. One of these secondary metabolites is xanthones, phomoxanthones A 99 and B 100, two novel xanthones dimmers both exhibited cytotoxic activity against KB cells, BC-1 cells and non-malignant cells [4,5] Isolate four new metabolites, chaetomugilins P–R and 11-epi-chaetomugilin I from C. globosum which significantly inhibited the growth of cultured P388, HL-60, L1210 and KB cell lines. Petroleum ether and ethyl acetate extracts of the liquid culture of C. globosum showed potent in vitro antioxidant activity, proved potent antibacterial activity and cytotoxic effect on human hepatocellular carcinoma cell line (HEPG-2) [6]. A novel cytotoxic chlorinated azaphilone derivative named chaetomugilin D, with chaetomugilin A, chaetoglobosins A and C, isolated by a bioassay-guided fractionation from the EtOAc extract of C. globosum [7,8] Isolate a new metabolite named chaetoglobosin X, together with three known compounds erogosterol, ergosterol 5α, 8-peroside and 2-methyl-3-hydroxy indole from C. globosum isolated from medicinal plant Curcuma wenyujin. Chaetoglobosin X exhibited a broader antifungal spectrum and showed the strongest cytotoxic activity against H22 and MFC cancer cell lines. Bioassay-guided fractionation of a cytotoxic EtOAc extract of the fungal strain, C. globosum, inhabiting the rhizosphere of the Christmas cactus, Opuntia leptocaulis, of the Sonoran desert was carried out by [9], where they afforded a new dihydroxanthenone, globosuxanthone A, a new tetrahydroxanthenone, globosuxanthone B, two new xanthones, globosuxanthone C and D, 2-hydroxyvertixanthone, and two known anthraquinones. Globosuxanthone A was found to exhibit strong cytotoxicity against a panel of seven human solid tumor cell lines, disrupt the cell cycle leading to the accumulation of cells in either G2/M or S phase, and induce classic signs of apoptosis. Previous studies of C. globosum resulted in isolation of chaetomin [10], chaetoglobosins A-B [11], C-F [12], G and J [13] Q, R, and T [14], 19-O-acetylchaetoglobosins B and D, TAN- 142 [15], heptelidic acid [16], dethio-tetra (methylthio) chaetomin [17], chaetovirindins A-D [18], prenisatin [19], PFI 138 A and B [20] chaetomanone and echinulin [21].

Material and Methods

Source of Chaetomium globosum

Chaetomium globosum were isolated from soil samples collected from Cairo University, Giza Governorate (5 cm depth). Serial dilution method was used for isolation of C. globosum on Czapek's media supplemented with carboxy methyl cellulose (CMC) as a sole carbon source and the medium was adjusted at pH 5.4. After inoculation on sterilized plates at 28°C, the grown fungal cultures were carefully and aseptically sub-cultured onto potato dextrose agar media (PDA) Fluka 70139 adjusted at pH 5.4 to obtain pure fungal culture. The fungal isolates were identified at Assiut University Mycological Center (AUMC), according to [22], using colony appearance and microscopic characteristics. Extraction and isolation of anticancer bioactive compounds

Identified C. globosum was inoculated in 1000 ml flasks each containing 300 ml potato dextrose broth by taking six agar disks with 1 cm in diameter. The flasks were incubated for 30 days at 28°C. For Extraction of anticancer bioactive compounds, 120 ml MeOH was added to contents of each flask and briefly sonicated. The resulting mixture was filtered through Whitman No.1 filter paper. The filtrate was concentrated to half of its original volume and then extracted by using 60 ml EtOAc for each 100 ml of the filtrate. Evaporation under reduced pressure afforded EtOAc crude extract. Test for anticancer potentiality of EtOAc crude extract on different cell lines

Cytotoxicity test for crude extract was carried out at Vacsera , Egypt using Sulforhodamine B protein cell survival assay (SRB); while cytotoxicity test for pure isolated compounds was carried out in Tierӓztlich Hochschule Hannover University, Germany using tetrazolium cell proliferation assay (MTT) on two different cancer cell lines : breast cancer cell line (MCF-7), human liver carcinoma cell line (HEPG-2). Fractionation of EtOAc extract

0.523 g of EtOAc extract was partitioned between hexane and 80% aqueous MeOH. Aqueous MeOH fraction was diluted to 60% aqueous MeOH by addition of water and extracted with CHCl3 then chloroform was Evaporated under reduced pressure using rotatory evaporator. 80 g of activated silica gel (mesh 63-200 µm Fluka 60741) was packed in glass column (3 cm in diameter and 40 cm height). 0.29 g of CHCl3 extract was dissolved in 1 ml of CHCl3 and loaded on the top of the silica gel column and then eluted by solvents with different polarities starting with hexane: chloroform: ethyl acetate 1:2:1/2; till 100% Ethyl acetate and finally with Ethyl acetate: Methanol 5:1- 1:1). According to the polarities of compound, the eluted fractions were categorized into 8 groups using precoated Thin Layer Chromatography (TLC) (20 cm × 20 cm with fluorescent indicator Fluka 60778) using chloroform: ethyl acetate 1:1 as solvent system. Purified individual compounds were isolated by preparative TLC using chloroform: ethyl acetate 1:1 as solvent system and then tested for their effectiveness against MCF-7 and HEPG-2 cell lines. Structure elucidation and characterization of pure compounds

Structure elucidation and characterization of positive tested compounds using Gas chromatography / mass spectroscopy (GC/MS-QP 2010 Plus) and NMR (The NMR spectra were recorded on a Varian Mercury VX-300 NMR spectrometer. 1 H spectra were run at 300 MHz was run at 75.46 MHz in deuterated chloroform (CDCl3). Chemical shifts are quoted in δ and were related to that of the solvents) used for identification of our compounds.

Results and Discussion

Cytotoxicity test was carried out for EtOAc crude extract on two different cancer cell lines Mcf-7 cell line; HEPG-2 cell line in Vacsera, Egypt using SRB cell survival assay. The cytotoxicity assay confirmed that crude extract can inhibit the proliferation and survival of the two tested cell line types. It was illustrated that there is no significant difference between half minimal inhibitory concentration (IC50) exhibited by both cell lines. IC50 of the MCF-7 cell line and HEPG-2 cell line was 147.8753 and 150.7043 µg/ml respectively. The toxicity showed by EtOAc crude extract was in accordance with results obtained by [9], where they reported the toxicity of C. globosum EtOAc crude extract grown on PDA media for 28 days at 27°C.

Fractionation of ethyl acetate crude extract was carried out using silica gel column chromatography. The fractions eluted from the column were categorized according to the compound polarities using precoated TLC into 8 groups (A, B, C, D, E, F, G and H) using hexane: chloroform: ethyl acetate as solvent system with different ratios. Purification of individual compounds from the most effective fraction (G) was carried out using preparative TLC. The purified compounds obtained from preparative TLC were checked on precoated TLC. By calculating Rf value of the pure compounds obtained compound 1 was at Rf 0.66 while compound 2 at Rf 0.55.

Testing the anticancer activity against MCF-7 and HEPG-2 cancer cell lines were carried out for the purified compounds (compound 1 and compound 2) in Tierӓztlich Hochschule Hannover University, Germany using MTT cell proliferation assay. The results showed that IC50 of compound 1 and 2 on MCF-7 are 136.59 and 151.68 µg/ml while, IC50 of compound 1 and 2 on HEPG-2 are 119.3 and 118.93 µg/ml respectively. Figure 1 showed the inhibitory effect of different concentrations of compound 1 and 2 on the proliferation of and survival of both tested cell lines in comparison with controls.


Figure 1: Effect of compound (1) and compound (2) on both MCF-7 and HEPG-2 cell lines.

Compound 1 was obtained as a pale yellow solid C15H12O7 by a combination of GC/MS and H NMR. GC/MS M+ 307 m/z and H NMR spectral data of 1(in CDCl3) revealed the presence of three aromatic protons in an AMX spin system [δ 7.66(t, J=8.3 Hz), 7.07(d, J=8.3 Hz), and 6.81(d, J=8.3 Hz)], two olefinic protons [δ 6.62 (dd, J=10.0,403 Hz) and 6.49 (d, J=10.0)], two hydroxyl groups[δ 5.85 (d, J= 8.4 Hz) and 5.70 (br s)], a proton attached to an oxygenated carbon [δ 4.26 (dd, J=8.4, 4.3 Hz)], and a methoxy group (δ 3.58). on the basis of chemical shifts, coupling constants and HMBC correlations, the two olefinic protons, two hydroxyl groups, and the proton attached to an oxygenated carbon were assigned to a –CH=CH-CH(OH)-C(OH) spin system with Z configuration of the double bond.

Compound 2 was obtained with no color solid C10H18O2 by a combination of GC/MS and H NMR. GC/MS M+170 m/z and H NMR spectral data of 2(in CDCl3) revealed the presence of two olefinic protons [δ 6.62 (dd, J=10.0, 403 Hz) and 6.49 (d, J=10.0)], one hydroxyl groups [δ 5.85 (d, J= 8.4 Hz)], a proton attached to an oxygenated carbon [δ 4.26 (dd, J=8.4, 4.3 Hz)], and a methoxy group (δ 2.2). H NMR of compound 2 was very similar to compound 1 but without aromatic protons. These results are with agreement with [9] (Figure 2).


Figure 2: Structure of (compound 1), Methyl 9-dihydro- 8- trihydroxy-9-oxo-H-xanthene-1-carboxylate and (compound 2) (E)-methyl 2-hydroxy-6, 6-dimethyl hept-3-enoate.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 11969
  • [From(publication date):
    April-2015 - Aug 19, 2017]
  • Breakdown by view type
  • HTML page views : 8122
  • PDF downloads :3847

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version